The European cell sheet-based gene treatment market is experiencing significant expansion. This sector is driven by an increasing demand for innovative therapeutic solutions to address a wide range of genetic conditions. Successful clinical trials and regulatory authorizations are fueling market momentum. A key factor contributing to this trend is